Literaturseite ADAMTS-13

Literature for TECHNOZYM^®ADAMTS-13

Posters Sarig G. et al. ADAMTS-13 activity, antigen and inhibitor antibodies in TTP patients ? a single center experience 2009, Rambam, Israel
Knöbl P. et al. Monitoring of ADAMTS-13 in patients with thrombotic thrombocytopenic purpura: Predicition of response to therapie, risk of relapse, and long-therm outcome GTH 2009, Vienna
Geiter S. et al. ADAMTS-13 activity, ADAMTS-13 and vWF antigen concentration and the risk of mycocardial infarction GTH 2009, Vienna
Geiter S. et al. Correlation between two ADAMTS-13 activity assays based on different principles GTH 2008, Wiesbaden
Bongers T. et al. Reduced levels of ADAMTS13 are associat4ed with an increased risk of arterial thrombosis in young individuals ISTH 2007, Geneva
Knöbl P. et al. Serial monitoring of ADAMTS13 and vWF-related parameters in patients with thrombitic thrombotcytopenic purpura ISTH 2007, Geneva
Ronda A. al. A Comparison of Two Commercial ADAMTS-13 Activity Assays with a Reference Laboratory Method ISTH 2007, Geneva
Geiter S. et al. Quantification of ADAMTS-13 Activity and Antigen from the Same Sample by a newly developed Combi-Actibind Assay (TECHNOZYM^® ADAMTS-13) ASH 2006, Orlando
Colle S. et al. Quantification of ADAMTS-13 activity and antigen from the same sample by a newly developed combi-actibind assay (TECHNOZYM^® ADAMTS-13) DGKL 2006 Mannheim & ÖGLMKC 2006 Salzburg
Kannicht C. et al. Detection of low levels of ADAMTS13 in the high-purity VWF/FVIII concentrate Wilate and ohter commercially available VWF-Containing FVIII concentrates. GTH Basel 2006, P233
Vetr H. et al. TECHNOZYM^® ADAMTS-13 Assays for Analyzing the vWF Cleaving Protease ADAMTS-13. Poster ISTH Sydney 2005, P0875
Literature K. Freynhofer et al. Levels of von Willebrand factor and ADMATS13 determine clinical outcome after dardoversion for atrial fibrillation Schattauer 2011; Thrombosis and Haemostasis 105.3/2011; 435-443
Jilma-Stohlawetz P. et al.. Inhibiton of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura Schattauer 2011; Thrombosis and Haemostasis 105.3/2011; 445-452
Bongers T. et al. Reduces ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome 2010; Schauttauer, Thrombosis and Heamostasis 103.6/2010; 1181-1187
Bongers T. et al. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients Atherosclerosis 207 (2009) 250?254
Skeppholm M. et al. ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus 2009, Blood Coagulation and Fibrinolysis 2009, 20:619?626
Rona A. et al. A Comparison of Two Commercial ADAMTS13 Activity Assays With a Reference Laboratory Method 2009; LABMEDICINE; Vol. 40, No 4; 232-235
Swisher K. et al. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports Haematologica 2007: 92; 936-943
Riksen M.P. et al. Antibodies against the CUB1-2 domains fo ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship Haematologica 2007; 92:(6)e74-e76
Ferrari S. et al. Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity Blood, 1. April 2007, Vol. 109, No. 7: 2815-2822
Schenkman B. Role of ADAMTS-13 in Platelet Adhesion in Flow: Methods for Diagnosis of Thrombotic Thrombocytopenic Purpura PHT 2006; 35: 98-102
Ulinski T. et al. From Humoral Rejection to Generalized Thrombotic Microangiopathy - Role of Acquired ADATS13 Deficiency in a Renal Allograft Recipient American Journal of Transplantation 2006; 6: 3030-3036
Mckew SJ et al. Haemorrhage as a cause of maternal deaths in developing countries and the relationship to the availability of blood for transfusion BJH 2006; 133: 1-121
Luken B. M. et al. Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura Journal of Thrombosis and Haemostasis, 4: 2355-2364
Miyata T, Kokame K, Banno F. Measurement of ADAMTS13 activityand inhibitors. Curr Opin Hematol. 2005 Sep;12(5):384-9.
Kokame K, Nobe Y, Kokubo Y et al. FRETS-vWF73, a first fluorogenic substrate for ADAMTS13 assay. Br. J Haematol. 2005 Apr; 129(1):93-100.
Majerus EM, Anderson PJ, Sadler JE. Binding of ADAMTS13 to von Willebrand factor. J Biol Chem. 2005 Jun 10;280(23):21773-8.
Veyradier A.. and Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. Journal of Thrombosis and Haemostasis, 3: 2420?2427
Klaus C, Plaimauer B, Studt JD et al. Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. Blood. 2004;103:4514-4519.
Sadler JE, Moake JL, Miyata T, George JN. Recent advances in Thrombotic Thrombocytopenic Purpura. Hematol. 2004 407-423
Kokame K, Matsumoto M, Fumimura Y et al. vWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood. 2004 Jan 15;103(2):607-12
Fontana S, Hovinga JA, Studt JD et al. Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency. Semin Hematol. 2004;41:48-59.
Furlan M. et al. Proteolytic cleavage of von Willebrand factor by prevents uninvited clumping of blood platelets. J Thromb Haemost 2004; 2: 150-09
Tsai H.-M. et al. A journey from sickle cell anemia to ADAMTS13. J Thromb Haemost 2004; 2: 1510-14
Moake J.L. et al. Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura. J Thromb Haemost 2004; 2: 1515-21
Sadler JE. A new name in thrombosis, ADAMTS13. Proc Natl Acad Sci U S A. 2002;99: 11552-11554.
Dong J. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002 100(12) 4033-4039.
Zheng et al. Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura. J.Biol. Chem. 2001, 278(44)

Literature

Posters

Literature